Contact Us Investor Relations Site Map
Home > About CCPG > CCSB

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB), founded in 1964, is one of the largest API manufacturers in Taiwan. It has evolved into a biotechnology company from 2003 and is located near Taipei with a manufacturing site of 8.7 acres.

CCSB is a subsidiary of the China Chemical Pharmaceutical Group (CCPG). Its affiliates, China Chemical Pharmaceutical Corporation (CCPC) in Taiwan and Suzhou Chunghwa Chemical and Pharmaceutical Industrial Co. Ltd. (SCCPC) in Suzhou, China, constitute two of the largest pharmaceutical formulators in these areas. The most recent investment to construct and upgrade these three companies amounts to US$120 million.

CCSB has developed more than 30 API products including laxatives, anti-anxiety agents; antifungals; antihistamines; antiseptics; cardiovascular drugs; antiulcerants; skeletal muscle relaxants, hypolipaemics and immunosuppressants. Our products include Pravastatin, Rapamycin, Tacrolimus, Mycophenolate Mofetil, Methocarbamol, Metaxalone, Dexbromopheniramine Maleate, Alprazolam, Glipizide, ...etc. CCSB offers contract research and contract manufacturing in our FDA approved cGMP plants.

In 1984, CCSB was the first API manufacturer in Taiwan inspected and approved by FDA for cGMP compliance. CCSB has filed DMF's for 18 products with the FDA. In April 2002 and December 2005, CCSB passed again the FDA inspection of their cGMP plant to produce synthesis and biotechnology products. CCSB has filed DMF, EDMF and COS for several products.

In 1999 CCSB established a sales office, Pharmaports LLC in Exton, Pennsylvania, to promote its products and provide better services to the North American region. With 75% of business in North America and Europe, CCSB has been collaborating on API and advanced intermediate development and production with leading branded and generic drug companies for years.

Together, CCSB, CCPC and SCCPC, as the CCPG have formed an international network providing pharmaceutical ingredients and finished dosages. 

More information references  Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB)
泭第 忒儂泭 泭 忒儂潼泭